BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 34748992)

  • 1. Artificial intelligence for the discovery of novel antimicrobial agents for emerging infectious diseases.
    Bess A; Berglind F; Mukhopadhyay S; Brylinski M; Griggs N; Cho T; Galliano C; Wasan KM
    Drug Discov Today; 2022 Apr; 27(4):1099-1107. PubMed ID: 34748992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial intelligence in COVID-19 drug repurposing.
    Zhou Y; Wang F; Tang J; Nussinov R; Cheng F
    Lancet Digit Health; 2020 Dec; 2(12):e667-e676. PubMed ID: 32984792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence as a smart approach to develop antimicrobial drug molecules: A paradigm to combat drug-resistant infections.
    Talat A; Khan AU
    Drug Discov Today; 2023 Apr; 28(4):103491. PubMed ID: 36646245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of artificial intelligence and machine learning for COVID-19 drug discovery and vaccine design.
    Lv H; Shi L; Berkenpas JW; Dao FY; Zulfiqar H; Ding H; Zhang Y; Yang L; Cao R
    Brief Bioinform; 2021 Nov; 22(6):. PubMed ID: 34410360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging role of artificial intelligence in therapeutics for COVID-19: a systematic review.
    Kaushal K; Sarma P; Rana SV; Medhi B; Naithani M
    J Biomol Struct Dyn; 2022 Jul; 40(10):4750-4765. PubMed ID: 33300456
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial Intelligence in Accelerating Drug Discovery and Development.
    Tripathi A; Misra K; Dhanuka R; Singh JP
    Recent Pat Biotechnol; 2023; 17(1):9-23. PubMed ID: 35927896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial Intelligence Technologies for COVID-19 De Novo Drug Design.
    Floresta G; Zagni C; Gentile D; Patamia V; Rescifina A
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Artificial intelligence and machine learning assisted drug delivery for effective treatment of infectious diseases.
    He S; Leanse LG; Feng Y
    Adv Drug Deliv Rev; 2021 Nov; 178():113922. PubMed ID: 34461198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AI-based language models powering drug discovery and development.
    Liu Z; Roberts RA; Lal-Nag M; Chen X; Huang R; Tong W
    Drug Discov Today; 2021 Nov; 26(11):2593-2607. PubMed ID: 34216835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Leveraging artificial intelligence in the fight against infectious diseases.
    Wong F; de la Fuente-Nunez C; Collins JJ
    Science; 2023 Jul; 381(6654):164-170. PubMed ID: 37440620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fighting COVID-19 with Artificial Intelligence.
    Monteleone S; Kellici TF; Southey M; Bodkin MJ; Heifetz A
    Methods Mol Biol; 2022; 2390():103-112. PubMed ID: 34731465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergence of New Disease: How Can Artificial Intelligence Help?
    Park Y; Casey D; Joshi I; Zhu J; Cheng F
    Trends Mol Med; 2020 Jul; 26(7):627-629. PubMed ID: 32418724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Updated Review of Computer-Aided Drug Design and Its Application to COVID-19.
    Gurung AB; Ali MA; Lee J; Farah MA; Al-Anazi KM
    Biomed Res Int; 2021; 2021():8853056. PubMed ID: 34258282
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Infectious Coronavirus Disease 2019 (COVID-19) with Artificial Intelligence (AI) Applications: Evidence Based Opinion.
    Mali SN; Pratap AP
    Infect Disord Drug Targets; 2021; 21(4):475-477. PubMed ID: 32568026
    [No Abstract]   [Full Text] [Related]  

  • 15. Artificial intelligence approach fighting COVID-19 with repurposing drugs.
    Ke YY; Peng TT; Yeh TK; Huang WZ; Chang SE; Wu SH; Hung HC; Hsu TA; Lee SJ; Song JS; Lin WH; Chiang TJ; Lin JH; Sytwu HK; Chen CT
    Biomed J; 2020 Aug; 43(4):355-362. PubMed ID: 32426387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial Intelligence in Drug Identification and Validation: A Scoping Review.
    Abubakar ML; Kapoor N; Sharma A; Gambhir L; Jasuja ND; Sharma G
    Drug Res (Stuttg); 2024 Jun; 74(5):208-219. PubMed ID: 38830370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rethinking Drug Repositioning and Development with Artificial Intelligence, Machine Learning, and Omics.
    Koromina M; Pandi MT; Patrinos GP
    OMICS; 2019 Nov; 23(11):539-548. PubMed ID: 31651216
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Bung N; Krishnan SR; Bulusu G; Roy A
    Future Med Chem; 2021 Mar; 13(6):575-585. PubMed ID: 33590764
    [No Abstract]   [Full Text] [Related]  

  • 19. Electrochemical SARS-CoV-2 Sensing at Point-of-Care and Artificial Intelligence for Intelligent COVID-19 Management.
    Kaushik AK; Dhau JS; Gohel H; Mishra YK; Kateb B; Kim NY; Goswami DY
    ACS Appl Bio Mater; 2020 Nov; 3(11):7306-7325. PubMed ID: 35019473
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Advancing Drug Discovery via Artificial Intelligence.
    Chan HCS; Shan H; Dahoun T; Vogel H; Yuan S
    Trends Pharmacol Sci; 2019 Aug; 40(8):592-604. PubMed ID: 31320117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.